Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 55:70-77, 2006
DOI: 10.2337/diabetes.55.01.06.db05-0632
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cozar-Castellano, I.
Right arrow Articles by Stewart, A. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cozar-Castellano, I.
Right arrow Articles by Stewart, A. F.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Islet Study

Evaluation of ß-Cell Replication in Mice Transgenic for Hepatocyte Growth Factor and Placental Lactogen

Comprehensive Characterization of the G1/S Regulatory Proteins Reveals Unique Involvement of p21cip

Irene Cozar-Castellano, Matthew Weinstock, Marcia Haught, Silvia Velázquez-Garcia, Darinka Sipula, and Andrew F. Stewart

Division of Endocrinology, The University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Address correspondence and reprint requests to Irene Cozar-Castellano, PhD, Division of Endocrinology, BST E-1140, University of Pittsburgh School of Medicine, 200 Lothrop St., Pittsburgh, PA 15213. E-mail: cozari{at}dom.pitt.edu

Abbreviations: CIP, cyclin inhibitory protein; HGF, hepatocyte growth factor; INK, inhibitory kinase; KIP, kinase inhibitory protein; PTHrP, parathyroid hormone–related protein; RIP, rat insulin promoter; RIP-PL, RIP-placental lactogen

We hypothesized that combined transgenic overexpression of hepatocyte growth factor (HGF) and placental lactogen in islets would lead to even greater increases in ß-cell mass and replication than either growth factor alone. This did not occur, suggesting that ß-cell replication is saturable or subject to molecular restraint. We therefore performed the first comprehensive G1/S cell cycle survey in islets, cataloguing the broad range of kinases, cyclins, and kinase inhibitors that control the G1/S transition in islets from normal, HGF, placental lactogen, and doubly transgenic mice. Many of the G1/S checkpoint regulators (E2Fs; pRb; p107; p130; cyclins D1,2,3, A, and E; cdk-2; cdk-4; p15; p16; p18; p19; p21; p27; MDM2; p53; c-Myc; and Egr-1) are present in the murine islet. Most of these proteins were unaltered by overexpression of HGF or placental lactogen, either alone or in combination. In contrast, p21cip was uniquely, dramatically, and reproducibly upregulated in placental lactogen and HGF islets. p21cip was also present in, and upregulated in, proliferating human islets, localizing specifically in ß-cells and translocating to the nucleus on mitogenic stimulation. Homozygous p21cip loss releases islets from growth inhibition, markedly enhancing proliferation in response to HGF and placental lactogen.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
L. C. Alonso, T. Yokoe, P. Zhang, D. K. Scott, S. K. Kim, C. P. O'Donnell, and A. Garcia-Ocana
Glucose Infusion in Mice: A New Model to Induce {beta}-Cell Replication
Diabetes, July 1, 2007; 56(7): 1792 - 1801.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
A. M Ackermann and M. Gannon
Molecular regulation of pancreatic {beta}-cell mass development, maintenance, and expansion
J. Mol. Endocrinol., February 1, 2007; 38(2): 193 - 206.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. C. Vasavada, I. Cozar-Castellano, D. Sipula, and A. F. Stewart
Tissue-Specific Deletion of the Retinoblastoma Protein in the Pancreatic {beta}-Cell Has Limited Effects on {beta}-Cell Replication, Mass, and Function
Diabetes, January 1, 2007; 56(1): 57 - 64.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
I. Cozar-Castellano, M. Haught, and A. F. Stewart
The Cell Cycle Inhibitory Protein p21cip Is Not Essential for Maintaining {beta}-Cell Cycle Arrest or {beta}-Cell Function In Vivo
Diabetes, December 1, 2006; 55(12): 3271 - 3278.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
I. Cozar-Castellano, N. Fiaschi-Taesch, T. A. Bigatel, K. K. Takane, A. Garcia-Ocana, R. Vasavada, and A. F. Stewart
Molecular Control of Cell Cycle Progression in the Pancreatic {beta}-Cell
Endocr. Rev., June 1, 2006; 27(4): 356 - 370.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
T. Yamada, H. Ishihara, A. Tamura, R. Takahashi, S. Yamaguchi, D. Takei, A. Tokita, C. Satake, F. Tashiro, H. Katagiri, et al.
WFS1-deficiency increases endoplasmic reticulum stress, impairs cell cycle progression and triggers the apoptotic pathway specifically in pancreatic {beta}-cells
Hum. Mol. Genet., May 15, 2006; 15(10): 1600 - 1609.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. Luo, S. M. Liu, H. Liu, Q. Li, Q. Xu, X. Sun, B. Davis, J. Li, and S. Chua Jr.
Allelic Variation on Chromosome 5 Controls {beta}-Cell Mass Expansion during Hyperglycemia in Leptin Receptor-Deficient Diabetes Mice
Endocrinology, May 1, 2006; 147(5): 2287 - 2295.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.